Long COVID - Medicines
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
Measures to improve care for long COVID patients: A report by the Long COVID Off-Label Use expert group, commissioned by the Federal Ministry of Health (BMG) (from page 8)
PDF DEUTSCH bfarm.de
View Resource (opens in new tab)